Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Surgical Site Infection Control Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.
After analyzing the global surgical site infection control market in detail, the publisher has concluded that the industry would display an upward trend, with a CAGR of 5.95% in terms of revenue in the forecasting years of 2021 to 2028.
Factors such as the adoption of best practices for infection prevention & control and growth in the elderly population are majorly fueling the growth of this industry. However, the lack of proper infection control programs is hindering this growth process. Moreover, the growing adoption of outpatient procedures and enhanced usage of medical disposable items are hampering the market growth even further. On the bright side, the growing incidence of surgical procedures and a significant increase in the occurrence of complications from HAIs are creating avenues for the growth of the surgical site infection control market.
The global market for surgical site infection control encompasses the regions of Latin America, Europe, North America, the Asia-Pacific, and the Middle East and Africa.
Latin America's SSI control market is projected to grow at the fastest rate globally in the forthcoming period. Brazil was plagued with the burden of surgical site infections in patients, affecting their safety. This, resulted in causing them suffering, pain, delayed healing, increased antibiotics usage, revision surgery, increased length of stays at hospitals, morbidity, and mortality rates. It also reflected in increased healthcare costs. Therefore, institutional surveillance was implemented by the Brazilian Ministry of Health in the year 1992, in order to address the growing need to control healthcare-associated infections, and has been practiced since. The ministry has made the establishment of an HAI control committee in private and public hospitals mandatory. Such factors are driving the growth of the Brazilian SSI control market.
The major competitors in this market are Pacon Manufacturing Corporation, 3M Company, Lac-Mac, Biomerieux SA, Steris Corporation, American Polyfilm, Gama Healthcare, Kimberly-Clark, Stryker Corporation, Becton Dickinson and Company (BD), Getinge AB, Belimed AG, Ansell Ltd, Johnson & Johnson, and Sotera Health LLC.
Becton Dickinson and Company (BD) is a globally renowned med-tech company. It develops, manufactures, and sells medical devices, diagnostic products, and laboratory equipment. The major products of the company include syringes & pen needles, IV catheters, infusion pumps & disposables, automated medication dispensing systems, respiratory ventilation & diagnostics equipment, diagnostics specimens, as well as instruments to detect numerous infectious diseases, healthcare-associated infections & cancers and various clinical research tools. Founded in 1897, the company operates across North America, Europe, Latin America, the Middle East and Africa, and the Asia-Pacific.
Key Topics Covered:
1. Global Surgical Site Infection Control Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Impact of Covid-19 on Surgical Site Infection Control Market
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Insights
2.7. Market Drivers
2.7.1. Enactment of the Best Infection Prevention and Control Practices
2.7.2. Growing Aging Population
2.8. Market Restraints
2.8.1. Lack of Infection Control Programs
2.8.2. Surging Use of Outpatient Procedures
2.8.3. Increased Usages of Medical Disposable Items
2.9. Market Opportunities
2.9.1. Rising Incidence of Surgical Procedures
2.9.2. Significant Rise in the Occurrence of Complications from Healthcare-Associated Infections
3. Surgical Site Infection Control Market Outlook - by Procedure
3.1. Laparoscopy
3.2. Orthopedic Surgery
3.3. Cardiovascular
3.4. Obstetrics and Gynecology
3.5. Wound Closure
3.6. Plastic & Reconstructive Surgery
3.7. Thoracic Surgery
3.8. Microvascular
3.9. Urology
3.10. Neurosurgery
3.11. Other Procedures
4. Surgical Site Infection Control Market Outlook - by Type of Infection
4.1. Superficial Incisional Ssi
4.2. Deep Incisional Ssi
4.3. Organ or Space Ssi
5. Surgical Site Infection Control Market Outlook - by Industry Vertical
5.1. Hospitals
5.2. Ambulatory Surgical Centers
6. Surgical Site Infection Control Market Outlook - by Product
6.1. Disinfectants
6.1.1.1. Skin Disinfectants
6.1.1.2. Hand Disinfectants
6.2. Manual Reprocessors Solution
6.3. Surgical Drapes
6.4. Surgical Gloves
6.5. Skin Preparation Solution
6.6. Surgical Irrigation
6.7. Surgical Scrubs
6.8. Hair Clippers
6.9. Medical Nonwovens
6.10. Other Products
7. Surgical Site Infection Control Market - Regional Outlook
7.1. North America
7.1.1. Market by Procedure
7.1.2. Market by Type of Infection
7.1.3. Market by Industry Vertical
7.1.4. Market by Product
7.1.5. Country Analysis
7.1.5.1. The United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market by Procedure
7.2.2. Market by Type of Infection
7.2.3. Market by Industry Vertical
7.2.4. Market by Product
7.2.5. Country Analysis
7.2.5.1. The United Kingdom
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Russia
7.2.5.6. Spain
7.2.5.7. Rest of Europe
7.3. Asia-Pacific
7.3.1. Market by Procedure
7.3.2. Market by Type of Infection
7.3.3. Market by Industry Vertical
7.3.4. Market by Product
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. Japan
7.3.5.3. India
7.3.5.4. Australia & New Zealand
7.3.5.5. South Korea
7.3.5.6. Asean Countries
7.3.5.7. Rest of Asia-Pacific
7.4. Latin America
7.4.1. Market by Procedure
7.4.2. Market by Type of Infection
7.4.3. Market by Industry Vertical
7.4.4. Market by Product
7.4.5. Country Analysis
7.4.5.1. Mexico
7.4.5.2. Brazil
7.4.5.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. Market by Procedure
7.5.2. Market by Type of Infection
7.5.3. Market by Industry Vertical
7.5.4. Market by Product
7.5.5. Country Analysis
7.5.5.1. Israel
7.5.5.2. Saudi Arabia
7.5.5.3. United Arab Emirates
7.5.5.4. Turkey
7.5.5.5. South Africa
7.5.5.6. Rest of Middle East & Africa
8. Company Profiles
8.1. Sotera Health LLC
8.2. Pacon Manufacturing Corporation
8.3. Steris Corporation
8.4. American Polyfilm
8.5. Biomerieux Sa
8.6. Stryker Corporation
8.7. Belimed AG
8.8. Gama Healthcare
8.9. Becton Dickinson and Company (Bd)
8.10. 3M Company
8.11. Getinge Ab
8.12. Johnson & Johnson
8.13. Ansell Ltd
8.14. Kimberly-Clark
8.15. Lac-Mac
9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis
For more information about this report visit https://www.researchandmarkets.com/r/lyk6nq
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.